Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Read full paper →- Authors
- Crystal S. Denlinger, Tara Sanft, K. Scott Baker, Gregory A. Broderick, Wendy Demark‐Wahnefried, Debra L. Friedman, Mindy Goldman, Melissa M. Hudson, Nazanin Khakpour, Allison A. King, Divya Koura, Robin M. Lally, Terry S. Langbaum, Allison L. McDonough, Michelle Melisko, José G. Montoya, Kathi Mooney, Javid J. Moslehi, Tracey L. O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, William F. Pirl, Maria Alma Rodriguez, Kathryn J. Ruddy, Paula Silverman, Sophia K. Smith, Karen L. Syrjala, Amyé Tevaarwerk, Susan G. Urba, Mark T. Wakabayashi, Phyllis C. Zee, Nicole R. McMillian, Deborah A. Freedman-Cass
- Journal
- Journal of the National Comprehensive Cancer Network
- Year
- 2018
- Citations
- 194
Abstract
The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period. This portion of the guidelines describes recommendations regarding the management of anthracycline-induced cardiotoxicity and lymphedema. In addition, recommendations regarding immunizations and the prevention of infections in cancer survivors are included.